Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Our initial products under development target the body’s largest organ, the skin. Our flagship technology, the CellMist™ System, uses our patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto ...
RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Our initial products under development target the body’s largest organ, the skin. Our flagship technology, the CellMist™ System, uses our patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. We’re also developing medical-grade liquid spray devices for wound care and irrigation fluids. In investigative clinical use in the United States, SkinGun™ treatments have shown the potential

List your booth number for exhibitions, ask us